English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52677723    在线人数 :  1125
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"lanoue b"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 1-3 / 3 (共1页)
1 
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2022-03-10T06:15:00Z Matching-adjusted indirect comparison of ribociclib plus fulvestrant versus palbociclib plus letrozole as first-line treatment of hr+/her2? advanced breast cancer Fasching P.A.; Delea T.E.; YEN-SHEN LU; De Boer R.; Hurvitz S.A.; Moynahan A.; Chandiwana D.; Lanoue B.; Hu H.; Thuerigen A.; O��shaughnessy J.
臺大學術典藏 2021-03-10T02:36:33Z Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7) Harbeck N.;Franke F.;Villanueva-Vazquez R.;Yen-Shen Lu;Tripathy D.;Chow L.;Babu G.K.;Im Y.-H.;Chandiwana D.;Gaur A.;Lanoue B.;Rodriguez-Lorenc K.;Bardia A.; Harbeck N.; Franke F.; Villanueva-Vazquez R.; YEN-SHEN LU; Tripathy D.; Chow L.; Babu G.K.; Im Y.-H.; Chandiwana D.; Gaur A.; Lanoue B.; Rodriguez-Lorenc K.; Bardia A.
臺大學術典藏 2021-03-10T02:36:33Z Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7) Harbeck N.;Franke F.;Villanueva-Vazquez R.;Yen-Shen Lu;Tripathy D.;Chow L.;Babu G.K.;Im Y.-H.;Chandiwana D.;Gaur A.;Lanoue B.;Rodriguez-Lorenc K.;Bardia A.; Harbeck N.; Franke F.; Villanueva-Vazquez R.; YEN-SHEN LU; Tripathy D.; Chow L.; Babu G.K.; Im Y.-H.; Chandiwana D.; Gaur A.; Lanoue B.; Rodriguez-Lorenc K.; Bardia A.

显示项目 1-3 / 3 (共1页)
1 
每页显示[10|25|50]项目